Astera Labs, Inc. $ALAB Shares Acquired by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC boosted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 48.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 24,401 shares of the company’s stock after buying an additional 8,005 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Astera Labs were worth $4,059,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of ALAB. Royal Bank of Canada raised its position in Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after buying an additional 95,409 shares during the last quarter. AQR Capital Management LLC lifted its position in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after purchasing an additional 7,756 shares during the period. Empowered Funds LLC lifted its position in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after purchasing an additional 4,183 shares during the period. First Trust Advisors LP lifted its position in Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after purchasing an additional 56,952 shares during the period. Finally, Brown Advisory Inc. lifted its position in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after purchasing an additional 1,977 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. This trade represents a 7.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,311,256 shares of company stock worth $477,341,446 in the last quarter. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

ALAB opened at $317.06 on Monday. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $372.37. The company has a fifty day moving average of $212.95 and a two-hundred day moving average of $171.81. The stock has a market capitalization of $54.35 billion, a price-to-earnings ratio of 214.23, a PEG ratio of 4.20 and a beta of 3.95.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to analysts’ expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.Astera Labs’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Morgan Stanley upped their target price on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. Evercore restated an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Susquehanna upped their target price on Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Finally, Royal Bank Of Canada raised their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $233.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.